{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T14:57:10Z","timestamp":1791385030341,"version":"4.3.3"},"reference-count":29,"publisher":"American Society of Tropical Medicine and Hygiene","issue":"4","license":[{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,7]]},"abstract":"<jats:title>ABSTRACT.<\/jats:title>\n                  <jats:p>This report presents the key proceedings and outcomes of three regional consultative workshops convened to review progress, identify challenges, and propose strategic actions for lymphatic filariasis elimination in India. The workshops were organized by the Indian Council of Medical Research-Vector Control Research Centre, Puducherry in collaboration with the Women\u2019s Collective Forum, New Delhi from June 2025 to August 2025. Consultations were held in three endemic states representing different regions of India (Uttar Pradesh, Gujarat, and Tamil Nadu), bringing together stakeholders from the national program, the WHO, donor agencies, nongovernmental organizations, academia, and research institutions. The consultations revealed that the nature of challenges varied considerably by region. Common challenges included gaps in mass drug administration (MDA) coverage and associated reporting and the persistence of never-treated populations. Shortfalls in diagnostic availability, surveillance capacity, and morbidity management services were also reported across regions. Rapid urbanization and an increase in informal settlements with poor facilities were identified as a cause of concern. Recommended programmatic actions included strengthening field supervision, real-time MDA monitoring, targeted strategies for never-treated and high-refusal populations, and improving diagnostic supplies and surveillance capacities. Context-specific interventions included migrant-focused surveillance and treatment, urban microplanning, and intensified post-MDA surveillance in areas that have passed transmission assessment surveys. Long-term priorities included strengthening intersectoral coordination, scaling up molecular xenomonitoring for vector surveillance, and expanding public\u2013private partnerships for morbidity management. Thus, the workshop enabled the identification and discussion of the critical region-specific challenges and also helped to provide operationally feasible strategies to address these issues.<\/jats:p>","DOI":"10.4269\/ajtmh.26-0054","type":"journal-article","created":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T16:50:49Z","timestamp":1787849449000},"page":"869-877","source":"Crossref","is-referenced-by-count":0,"title":["Multistakeholder Consultations on Programmatic Progress, Challenges, and Policy Priorities for Lymphatic Filariasis Elimination in India"],"prefix":"10.4269","volume":"115","author":[{"given":"Muhammed","family":"Jabir","sequence":"first","affiliation":[{"name":"Indian Council of Medical Research-Vector Control Research Centre, Indira Nagar, Puducherry, India;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raja Jeyapal","family":"Dinesh","sequence":"additional","affiliation":[{"name":"Indian Council of Medical Research-Vector Control Research Centre, Indira Nagar, Puducherry, India;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adinarayanan","family":"Srividya","sequence":"additional","affiliation":[{"name":"Indian Council of Medical Research-Vector Control Research Centre, Indira Nagar, Puducherry, India;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anju","family":"Viswan","sequence":"additional","affiliation":[{"name":"Indian Council of Medical Research-Vector Control Research Centre, Indira Nagar, Puducherry, India;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manikandan","family":"Kishanthini","sequence":"additional","affiliation":[{"name":"Indian Council of Medical Research-Vector Control Research Centre, Indira Nagar, Puducherry, India;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richa","family":"Sharma","sequence":"additional","affiliation":[{"name":"Women\u2019s Collective Forum, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manju","family":"Rahi","sequence":"additional","affiliation":[{"name":"Indian Council of Medical Research-Vector Control Research Centre, Indira Nagar, Puducherry, India;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2795","reference":[{"key":"b1","article-title":"Lymphatic Filariasis.","year":"2024"},{"key":"b2","article-title":"Revised Guideline on Elimination of Lymphatic Filariasis 2024.","year":"2024"},{"key":"b3","series-title":"Am J Trop Med Hyg","first-page":"29","article-title":"Introduction of triple-drug therapy for accelerating lymphatic filariasis elimination in India: Lessons learned","volume":"106","author":"Tripathi","year":"2022"},{"key":"b4","article-title":"VL\/LF Update.","year":"2023"},{"key":"b5","article-title":"Global Programme to Eliminate Lymphatic Filariasis: Progress Report, 2024.","year":"2025"},{"key":"b6","article-title":"Nationwide Mass Drug Administration Campaign for Lymphatic Filariasis Elimination\u2014India on Mission Mode to Eliminate Filariasis by 2027.","year":"2024"},{"key":"b7","article-title":"Magnitude of Disease.","year":"2025"},{"issue":"7","key":"b8","series-title":"BMJ Glob Health","first-page":"e018851","article-title":"Global insights can accelerate India\u2019s journey towards the elimination of lymphatic filariasis as a public health problem","volume":"10","author":"Jabir","year":"2025"},{"key":"b9","series-title":"IJID Reg","first-page":"100773","article-title":"Two decades of filariasis in India: Insights into prevalence, diagnostic challenges, and strategies for elimination by 2027","volume":"17","author":"Singh","year":"2025"},{"key":"b10","series-title":"Front Public Health","first-page":"1384131","article-title":"Impediments to compliance during filariasis mass drug administration\u2014Observations and recommendations to accelerate filariasis elimination in India","volume":"12","author":"Abraham","year":"2024"},{"issue":"1","key":"b11","series-title":"PLoS Negl Trop Dis","first-page":"e0007862","article-title":"Molecular xenomonitoring as a post-MDA surveillance tool for global programme to eliminate lymphatic filariasis: Field validation in an evaluation unit in India","volume":"14","author":"Subramanian","year":"2020"},{"issue":"2","key":"b12","series-title":"PLoS Negl Trop Dis","first-page":"e0009069","article-title":"An open-label, block randomized, community study of the safety and efficacy of co-administered ivermectin, diethylcarbamazine plus albendazole vs. diethylcarbamazine plus albendazole for lymphatic filariasis in India","volume":"15","author":"Jambulingam","year":"2021"},{"key":"b13","article-title":"Monitoring and Epidemiological Assessment of Mass Drug Administration in the Global Programme to Eliminate Lymphatic Filariasis: A Manual for National Elimination Programmes, Second Edition.","year":"2025"},{"issue":"2","key":"b14","series-title":"J Vector Borne Dis","first-page":"172","article-title":"Coverage and evaluation survey of post-mass drug administration for lymphatic filariasis in four endemic districts of Uttar Pradesh: Are we on the track?","volume":"62","author":"Paul","year":"2025"},{"issue":"3","key":"b15","series-title":"Indian J Public Health","first-page":"345","article-title":"Eliminating lymphatic filariasis: India\u2019s bold plan to finish 3 years ahead of global schedule","volume":"67","author":"Pati","year":"2023"},{"key":"b16","article-title":"Ministry of Health & Family Welfare Launches Nationwide Sarva Dawa Sevan or Mass Drug Administration (MDA) Campaign to Eliminate Lymphatic Filariasis (LF).","year":"2023"},{"issue":"9","key":"b17","series-title":"Asian Pac J Trop Med","first-page":"385","article-title":"Elimination of lymphatic filariasis: Where do we stand so far?","volume":"16","author":"Sinha","year":"2023"},{"issue":"1","key":"b18","series-title":"Infect Dis Poverty","first-page":"73","article-title":"Lymphatic filariasis elimination endgame in an urban Indian setting: The roles of surveillance and residual microfilaremia after mass drug administration","volume":"10","author":"Modi","year":"2021"},{"issue":"9","key":"b19","series-title":"PLoS Negl Trop Dis","first-page":"e0011588","article-title":"Coverage evaluation of mass drug administration with triple drug regimen in an evaluation unit in Nagpur district of Maharashtra, India","volume":"17","author":"Dinesh","year":"2023"},{"issue":"1","key":"b20","series-title":"Parasitol Res","first-page":"35","article-title":"Urban lymphatic filariasis","volume":"112","author":"Simonsen","year":"2013"},{"issue":"3","key":"b21","series-title":"PLoS Negl Trop Dis","first-page":"e2079","article-title":"Population migration: Implications for lymphatic filariasis elimination programmes","volume":"7","author":"Ramaiah","year":"2013"},{"issue":"3","key":"b22","series-title":"J Immigr Minor Health","first-page":"563","article-title":"Prevalence of neglected tropical diseases (leishmaniasis and lymphatic filariasis) and malaria among a migrant labour settlement in Kerala, India","volume":"21","author":"George","year":"2019"},{"issue":"1","key":"b23","series-title":"Indian J Community Health","first-page":"84","article-title":"Lymphatic filariasis in migrant population in non-endemic states\u2014Need to cover by mass drug administration (MDA)","volume":"28","author":"Verma","year":"2016"},{"key":"b24","series-title":"Clin Infect Dis","first-page":"S93","article-title":"How does the proportion of never treatment influence the success of mass drug administration programs for the elimination of lymphatic filariasis?","volume":"78","author":"Kura","year":"2024"},{"issue":"5","key":"b25","series-title":"Int Health","first-page":"479","article-title":"Persons \u201cnever treated\u201d in mass drug administration for lymphatic filariasis: Identifying programmatic and research needs from a series of research review meetings 2020\u20132021","volume":"16","author":"Brady","year":"2024"},{"key":"b26","article-title":"Reaching Never-Treated People to Eliminate Neglected Tropical Diseases: A Toolkit for National Programmes.","year":"2025"},{"key":"b27","series-title":"Lancet Reg Health Southeast Asia","first-page":"100400","article-title":"Empowering lymphatic filariasis affected individuals in India: Acknowledging disability status and ensuring justice","volume":"25","author":"Joy","year":"2024"},{"issue":"1","key":"b28","series-title":"ScientificWorldJournal","first-page":"372618","article-title":"Issues in delivering morbidity management for lymphatic filariasis elimination: A study in Pondicherry, South India","volume":"2012","author":"Kumari","year":"2012"},{"key":"b29","series-title":"Acta Trop","first-page":"107590","article-title":"Access, utilisation and barriers to lymphedema care: A mixed method study in Puducherry, India","volume":"264","author":"Jabir","year":"2025"}],"container-title":["The American Journal of Tropical Medicine and Hygiene"],"original-title":[],"link":[{"URL":"https:\/\/www.ajtmh.org\/view\/journals\/tpmd\/115\/4\/article-p869.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.ajtmh.org\/downloadpdf\/journals\/tpmd\/115\/4\/article-p869.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/www.ajtmh.org\/downloadpdf\/journals\/tpmd\/115\/4\/article-p869.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T14:24:27Z","timestamp":1791383067000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ajtmh.org\/view\/journals\/tpmd\/115\/4\/article-p869.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,7]]},"references-count":29,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.4269\/ajtmh.26-0054","relation":{},"ISSN":["0002-9637","1476-1645"],"issn-type":[{"value":"0002-9637","type":"print"},{"value":"1476-1645","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,7]]}}}